RESUMO
The biochemical characteristics of hemorrhagic metalloproteinases isolated from snake venoms are reviewed, together with their role in the pathogenesis of the local tissue damage characteristic of crotaline and viperine snake envenomations. Venom metalloproteinases differ in their domain structure. Some enzymes comprise only the metalloproteinase domain, others have disintegrin-like and high cysteine domains and others present, besides these domains, an additional lectin-like subunit. All of them are zinc-dependent enzymes with highly similar zinc binding environments. Some metalloproteinases induce hemorrhage by directly affecting mostly capillary blood vessels. It is suggested that hemorrhagic enzymes cleave, in a highly selective fashion, key peptide bonds of basement membrane components, thereby affecting the interaction between basement membrane and endothelial cells. As a consequence, these cells undergo a series of morphological and functional alterations in vivo, probably associated with biophysical hemodynamic factors such as tangential fluid shear stress. Eventually, gaps are formed in endothelial cells through which extravasation occurs. In addition to hemorrhage, venom metalloproteinases induce skeletal muscle damage, myonecrosis, which seems to be secondary to the ischemia that ensues in muscle tissue as a consequence of bleeding and reduced perfusion. Microvessel disruption by metalloproteinases also impairs skeletal muscle regeneration, being therefore responsible of fibrosis and permanent tissue loss after snakebites. Moreover, venom metalloproteinases participate in the degradation of extracellular matrix components and play a relevant role in the prominent local inflammatory response that characterizes snakebite envenomations, since they induce edema, activate endogenous matrix metalloproteinases (MMPs) and are capable of releasing TNF-alpha from its membrane-bound precursor. Owing to their protagonic role in the pathogenesis of local tissue damage, snake venom metalloproteinases constitute relevant targets for natural and synthetic inhibitors which may complement antivenoms in the neutralization of these effects.
Assuntos
Metaloendopeptidases/fisiologia , Mordeduras de Serpentes/etiologia , Venenos de Serpentes/enzimologia , Animais , Vesícula/etiologia , Humanos , Músculo Esquelético/patologia , Necrose , Mordeduras de Serpentes/enzimologiaRESUMO
The pathological alterations induced by neuwiedase, a 22 kDa class P-I metalloproteinase from the venom of the South American pit viper Bothrops neuwiedi, were studied in mice. Neuwiedase was devoid of hemorrhagic activity when tested in the skin up to a dose of 200 microgram, and also after intramuscular injection in the gastrocnemius. However, it induced bleeding when applied onto the mouse cremaster muscle in intravital microscopy experiments, and caused pulmonary hemorrhage when injected intravenously at doses higher than 5 microgram/g. Median lethal dose (LD(50)) by the intravenous route was 5 microgram/g, whereas LD(50) of crude venom was 0.47 microgram/g. After intramuscular injection, neuwiedase induced a mild myotoxic effect, evidenced histologically and by the increment in plasma creatine kinase activity, but it was devoid of hemorrhagic and thrombotic effects. In contrast, crude B. neuwiedi venom induced prominent hemorrhage and myonecrosis in gastrocnemius muscle. Both venom and neuwiedase induced an inflammatory reaction in muscle tissue characterized by abundant polymorphonuclear leukocytes. Moreover, a conspicuous edema developed in the foot pad after subcutaneous injection of neuwiedase. Anti-neuwiedase antibodies produced in rabbits were effective in the neutralization of hemorrhagic activity of crude venom, evidencing immunological cross-reactivity between neuwiedase and other hemorrhagic metalloproteinases present in the venom, and suggesting that metalloproteinases devoid of, or having low, hemorrhagic activity could be good immunogens to generate antibodies effective against high molecular mass metalloproteinasas having potent hemorrhagic activity. It is concluded that neuwiedase, despite its lack of hemorrhagic effect when injected in the gastrocnemius muscle, contributes to local tissue damage by inducing edema, inflammatory infiltrate and mild myotoxicity, and by degrading extracellular matrix components. In addition, large doses of neuwiedase may contribute to pulmonary bleeding
Assuntos
Bothrops , Venenos de Crotalídeos/enzimologia , Metaloendopeptidases/toxicidade , Venenos de Víboras/toxicidade , Animais , Anticorpos/imunologia , Anticorpos/farmacologia , Anticorpos/uso terapêutico , Creatina Quinase/metabolismo , Venenos de Crotalídeos/antagonistas & inibidores , Venenos de Crotalídeos/imunologia , Venenos de Crotalídeos/toxicidade , Edema/induzido quimicamente , Edema/tratamento farmacológico , Hemorragia/induzido quimicamente , Hemorragia/tratamento farmacológico , Técnicas In Vitro , Inflamação/induzido quimicamente , Inflamação/tratamento farmacológico , Dose Letal Mediana , Pulmão/efeitos dos fármacos , Pulmão/patologia , Masculino , Metaloendopeptidases/antagonistas & inibidores , Metaloendopeptidases/imunologia , Camundongos , Músculos/efeitos dos fármacos , Músculos/patologia , Testes de Neutralização , Fatores de Tempo , Venenos de Víboras/antagonistas & inibidores , Venenos de Víboras/imunologiaRESUMO
Thrombocytopenia occurs in a number of patients bitten by Bothrops asper, a species responsible for the majority of snakebites in Central America and southern Mexico. In this work we describe the isolation of a new platelet-aggregating protein, named aspercetin, from the venom of B. asper, which induces thrombocytopenia in mice. Isolation was carried out by a combination of ion-exchange chromatography on DEAE-Sepharose and affinity chromatography on Affi-Gel Blue. Aspercetin is a disulfide-linked heterodimer, with a pI of 4.5 and a molecular mass of 29,759 Da, detemined by MALDI-ESI mass spectrometry. N-terminal sequence shows homology with a number of venom proteins which belong to the C-type lectin family. Aspercetin has functional similarities with botrocetin, from B. jararaca venom, since it induces platelet aggregation only in the presence of plasma or purified von Willebrand factor. Aspercetin-mediated platelet aggregation results from the interaction of von Willebrand factor with platelet receptor GPIb. Aspercetin lacks anticoagulant effect and does not agglutinate erythrocytes, in contrast with other representatives of the C-type lectin family isolated from snake venoms. Moreover, aspercetin is not lethal, nor does it induce myonecrosis, hemorrhage and edema. When injected intravenously or intramuscularly in mice it induces a rapid, dose-dependent drop in platelet counts and prolongs the bleeding time, suggesting that it may play a role in the thrombocytopenia that develops in a number of B. asper envenomations. Moreover, mice injected intravenously with aspercetin and then receiving an intradermal injection of B. asper hemorrhagic metalloproteinase BaP1 develop a larger hemorrhagic lesion than mice receiving only BaP1. This suggests that aspercetin, by reducing platelet numbers, may
Assuntos
Bothrops/metabolismo , Venenos de Crotalídeos/química , Venenos de Crotalídeos/isolamento & purificação , Hemorragia/induzido quimicamente , Metaloendopeptidases/toxicidade , Agregação Plaquetária/efeitos dos fármacos , Trombocitopenia/induzido quimicamente , Sequência de Aminoácidos , Animais , Tempo de Sangramento , Cromatografia de Afinidade , Cromatografia por Troca Iônica , Venenos de Crotalídeos/administração & dosagem , Venenos de Crotalídeos/farmacologia , Venenos de Crotalídeos/toxicidade , Injeções Intradérmicas , Injeções Intramusculares , Injeções Intravenosas , Metaloendopeptidases/administração & dosagem , Camundongos , Dados de Sequência Molecular , Peso Molecular , Contagem de Plaquetas , Alinhamento de Sequência , Análise de Sequência de Proteína , Homologia de Sequência de Aminoácidos , Espectrometria de Massas por Ionização e Dessorção a Laser Assistida por MatrizRESUMO
Batimastat (BB-94), a synthetic hydroxamate peptidomimetic matrix metalloproteinase inhibitor, was tested for its ability to inhibit proteolytic and toxic effects induced by BaP1, a 24-kDa hemorrhagic metalloproteinase isolated from the venom of Bothrops asper, the medically most important snake species in Central America and southern Mexico. Batimastat inhibited proteolytic activity on biotinylated casein, with anIC(50) of 80 nM. In addition, batimastat was effective in inhibiting hemorrhagic, dermonecrotic, and edema-forming activities of this metalloproteinase if incubated with the enzyme prior to the assays. When the inhibitor was administered i.m. at the site of the toxin injection without preincubation, rapidly after metalloproteinase administration, it totally abrogated the hemorrhagic and dermonecrotic effects of BaP1. Inhibition was less effective as the time lapse between toxin and batimastat injection increased, due to the extremely rapid development of BaP1-induced local tissue damage in this experimental model. On the other hand, batimastat was ineffective if administered by the i.p. route immediately after toxin injection. It is concluded that batimastat, and probably other synthetic metalloproteinase inhibitors, may become useful therapeutic tools aimed at the in situ inhibition of venom metalloproteinases, when injected at the site of the bite rapidly after envenomation.
Assuntos
Bothrops , Carbono-Oxigênio Liases/antagonistas & inibidores , Venenos de Crotalídeos/enzimologia , Inibidores de Metaloproteinases de Matriz , Metaloendopeptidases/antagonistas & inibidores , Fenilalanina/análogos & derivados , Tiofenos/farmacologia , Animais , Carbono-Oxigênio Liases/toxicidade , Venenos de Crotalídeos/antagonistas & inibidores , Venenos de Crotalídeos/toxicidade , DNA Liase (Sítios Apurínicos ou Apirimidínicos) , Desoxirribonuclease IV (Fago T4-Induzido) , Interações Medicamentosas , Edema/prevenção & controle , Hemorragia/induzido quimicamente , Hemorragia/prevenção & controle , Metaloendopeptidases/toxicidade , Camundongos , Fenilalanina/farmacologia , Fenilalanina/uso terapêutico , Inibidores de Proteases/farmacologia , Inibidores de Proteases/uso terapêutico , Tiofenos/uso terapêuticoRESUMO
Anti-bothropic complex (ABC) was isolated from the serum of the South American opossum (Didelphis albiventris) by single-step affinity chromatography using a Sepharose-immobilized metalloprotease (BaP1) from Bothrops asper as the binding protein. Biochemical characterization of ABC showed the presence of two glycosylated subunits of 43 and 45 kDa, respectively, with an isoelectric point < 4. The two subunits were separated by ion-exchange HPLC. The N-terminal sequences of both subunits (LKAMDPTPXLWIETESP, where X is Arg-9 and Pro-9, respectively) showed a high degree of identity with other serum inhibitors isolated from different marsupials. Functional studies pointed out that ABC inhibits the hemorrhagic and proteolytic activities on fibrin, fibrinogen, and casein induced by the metalloproteases BaP1 and BaH4 isolated from B. asper venom. In addition to the anti-hemorrhagic and anti-proteolytic activities, ABC also showed anti-myotoxic, anti-lethal, and anti-edematogenic effects against myotoxic phospholipases A(2) isolated from the same venom. Moreover, it had inhibitory effects on the phospholipase A(2) activity of the crude venom as well as the isolated venom phospholipases A(2).
Assuntos
Proteínas Sanguíneas/farmacologia , Proteínas de Transporte/farmacologia , Venenos de Crotalídeos/antagonistas & inibidores , Metaloendopeptidases/antagonistas & inibidores , Neurotoxinas/antagonistas & inibidores , Gambás/sangue , Fosfolipases A/antagonistas & inibidores , Aminoácidos/química , Animais , Proteínas Sanguíneas/química , Proteínas Sanguíneas/isolamento & purificação , Bothrops , Proteínas de Transporte/química , Proteínas de Transporte/isolamento & purificação , Venenos de Crotalídeos/química , Venenos de Crotalídeos/enzimologia , Fosfolipases A2 do Grupo II , Hemorragia/prevenção & controle , Proteínas de Répteis , Análise de Sequência de ProteínaRESUMO
The effectiveness of the chelating agent CaNa2EDTA and the peptidomimetic matrix metalloproteinase inhibitor batimastat (BB-94) to inhibit local tissue damage induced by Bothrops asper snake venom was studied in mice. Both compounds totally inhibited proteolytic, hemorrhagic, and dermonecrotic effects, and partially reduced edema-forming activity, when incubated with venom prior to injection. Much lower concentrations of batimastat than of CaNa2EDTA were required to inhibit these effects. In addition, batimastat, but not CaNa2EDTA, partially reduced myotoxic activity of the venom. When the inhibitors were administered at various time intervals after envenomation at the same site of venom injection, both compounds were effective in neutralizing local hemorrhage and dermonecrosis if administered rapidly after venom. Inhibition was not as effective as the time lapse between venom and inhibitor injections increased. Owing to the relevance of metalloproteinases in the pathogenesis of local tissue damage induced by B. asper and other pit viper venoms, it is suggested that administration of peptidomimetic metalloproteinase inhibitors or CaNa2EDTA at the site of venom injection may represent a useful alternative to complement antivenoms in the neutralization of venom-induced local tissue damage.
Assuntos
Bothrops , Quelantes/administração & dosagem , Venenos de Crotalídeos , Ácido Edético/administração & dosagem , Hemorragia/prevenção & controle , Inibidores de Metaloproteinases de Matriz , Fenilalanina/análogos & derivados , Fenilalanina/administração & dosagem , Mordeduras de Serpentes/terapia , Tiofenos/administração & dosagem , Animais , Modelos Animais de Doenças , Injeções Intralesionais , Camundongos , NecroseRESUMO
The ability of pre-existing antibodies to neutralize locally-acting toxins of Bothrops asper snake venom was investigated. Hemorrhage, myonecrosis, and edema were markedly reduced in actively immunized mice, although none of these effects was completely abolished. In mice passively immunized with equine antivenom, hemorrhage was prevented completely, while myonecrosis and edema were partially reduced. Pre-existing antibodies did not modify the early stage (< 3 hr) of venom-induced edema, but significantly accelerated the normalization of this effect within 24 hr. Passive administration of antivenom either 5 or 120 min before venom injection gave similar results, suggesting that the presence of antibodies in the intravascular compartment may fully neutralize locally acting toxins, in this experimental animal model. Overall, the homologous or heterologous origin of antibodies was not a significant factor influencing their in vivo neutralizing efficiency against local venom effects. Antibody titrations by enzyme-immunoassay using purified toxins and whole venom indicated that serum from actively-immunized mice had a higher proportion of anti-myotoxin antibodies than equine antivenom.
Assuntos
Anticorpos Heterófilos/imunologia , Venenos de Crotalídeos/toxicidade , Edema/terapia , Animais , Anticorpos Heterófilos/uso terapêutico , Formação de Anticorpos , Antivenenos/uso terapêutico , Bothrops , Venenos de Crotalídeos/administração & dosagem , Modelos Animais de Doenças , Hemorragia/prevenção & controle , Cavalos , Imunização Passiva , Técnicas Imunoenzimáticas , Camundongos , VacinaçãoRESUMO
A hemorrhagic metalloproteinase, named BaH4, was isolated from the venom of the snake Bothrops asper by a combination of ion-exchange chromatography on DEAE-Sepharose and gel filtration on Sephacryl S-200. BaH4 is a 69 kDa protein with a pI of 5.3. It was recognized by antibodies raised against hemorrhagic metalloproteinase BaH1 isolated from B. asper venom, with a reaction of partial immunologic identity. BaH4 shows proteolytic activity on biotinylated casein, hide powder azure and fibrin, although having lower activity than crude B. asper venom and metalloproteinase BaP1 isolated from the same venom. BaH4 hydrolyzed fibronectin, laminin and type IV collagen in vitro, albeit at a relatively high enzyme:substrate ratio. Proteolytic activity was inhibited by chelating agents and 2-mercaptoethanol, but not by soybean trypsin inhibitor. Prominent hemorrhage developed in gastrocnemius and cremaster muscles after administration of BaH4. Moreover, it induced lethality in mice after intravenous injection, with an LD50 of 0.37 microg/g. Histological observations showed conspicuous pulmonary hemorrhage when the enzyme was injected intravenously. BaH4 is a hemorrhagic metalloproteinase which may play a relevant role in local and systemic bleeding characteristic of B. asper envenomations.
Assuntos
Bothrops , Venenos de Crotalídeos/enzimologia , Venenos de Crotalídeos/isolamento & purificação , Venenos de Crotalídeos/farmacologia , Hemorragia/induzido quimicamente , Metaloendopeptidases/isolamento & purificação , Metaloendopeptidases/toxicidade , Animais , Cromatografia por Troca Iônica , Venenos de Crotalídeos/química , Venenos de Crotalídeos/toxicidade , Eletroforese em Gel de Poliacrilamida , Matriz Extracelular/metabolismo , Fibrinólise/efeitos dos fármacos , Hemorragia/patologia , Imuno-Histoquímica , Masculino , Camundongos , Músculo Esquelético/patologiaRESUMO
No immunological cross-reactivity was observed between BaH1 and BaP1, two hemorrhagic metalloproteinases isolated from B. asper venom, by gel immunodiffusion, Western blotting and neutralization studies. Cross-reactivity was detected with antisera against these toxins in several crotaline and viperine snake venoms by ELISA, whereas no reactivity was observed with either antiserum against the venoms of Bothrops nummifer, Crotalus durissus terrificus, Vipera russelli and several elapid venoms. Antiserum against native BaH1 neutralized hemorrhagic activity of the venoms of B. asper, B. atrox, B. jararaca, Crotalus atrox, C. durissus durissus, Echis carinatus and Trimeresurus flavoviridis, being ineffective against the venoms of Agkistrodon bilineatus and Lachesis muta.
Assuntos
Venenos de Crotalídeos/enzimologia , Venenos de Crotalídeos/imunologia , Hemorragia/induzido quimicamente , Metaloendopeptidases/imunologia , Animais , Bothrops , Hemorragia/imunologia , Soros Imunes/farmacologia , Metaloendopeptidases/toxicidadeRESUMO
Local tissue damage induced by LHF-II, a 22-kDa hemorrhagic metalloproteinase from Lachesis muta venom was studied. Intravital microscopy experiments evidenced hemorrhagic events 2 min after LHF-II application onto cremaster muscle, characterized by microhemorrhages in capillary vessels and venules. However, histological analysis showed only mild hemorrhage in the gastrocnemius muscle. LHF-II degraded laminin, fibronectin and type IV collagen upon incubation in vitro, but was not cytotoxic to capillary endothelial cells in culture. Intramuscular injection of LHF-II induced a mild myonecrosis, with early small increments in plasma creatine kinase activity. It also induced edema in the mouse footpad at doses where hemorrhage is absent. Injection of LHF-II induced the synthesis of matrix metalloproteinases evidenced in muscle homogenates and in exudate samples. It is concluded that LHF-II has weak hemorrhagic and myotoxic activities, and that its role in the pathogenesis of L. muta-induced local tissue damage is associated with edema formation and degradation of extracellular matrix components, either directly or by activation of endogenous matrix metalloproteinases.
Assuntos
Hemorragia/induzido quimicamente , Metaloendopeptidases/toxicidade , Microcirculação/efeitos dos fármacos , Músculo Esquelético/efeitos dos fármacos , Venenos de Serpentes/toxicidade , Viperidae/fisiologia , Animais , Capilares/efeitos dos fármacos , Células Cultivadas , Creatina Quinase/metabolismo , Edema/induzido quimicamente , Extravasamento de Materiais Terapêuticos e Diagnósticos/patologia , Pé/fisiologia , Hemorragia/patologia , Injeções Intramusculares , Camundongos , Músculo Esquelético/patologia , Necrose , Peptídeo Hidrolases/farmacologia , Fosfolipases A/metabolismo , Vênulas/efeitos dos fármacosRESUMO
Local tissue damage represents a serious consequence of Bothrops asper envenomations. It encompasses a complex series of alterations, including myonecrosis, dermonecrosis, hemorrhage and edema. Due to its rapid development it is difficult to neutralize by antivenoms, especially if there is a delay in serotherapy. Experimental studies with this venom and the polyvalent (Crotalinae) antivenom produced in Costa Rica indicate that antivenom is effective in neutralizing these toxic activities when incubated with the venom prior to injection. However, if venom and antivenom are injected independently in mice, neutralization of these effects is only partial. Moreover, neutralization is not complete even if homologous or heterologous antibodies are present in the circulation before venom is injected. Despite differences in their pharmacokinetic profiles, equine whole IgG and F(ab')2 antivenoms show similar efficacy in the neutralization of edema, hemorrhage and myonecrosis induced by B. asper venom, suggesting that the use of antivenoms made of antibody fragments may not improve neutralization of these effects. This is due, at least in part, to the fact that microvessel disruption by venom components favors a similar antibody concentration in the affected tissues. Recent advances in the development of neutralizing substances of rapid diffusion, that could be injected locally in the field, may contribute to the neutralization of metalloproteinases and phospholipases A2. In addition, the rapid administration of antivenoms with high antibody titers against locally-acting toxins is very important in the treatment of these effects.
Assuntos
Antivenenos/uso terapêutico , Venenos de Crotalídeos/toxicidade , Mordeduras de Serpentes/terapia , Animais , Bothrops , Venenos de Crotalídeos/imunologia , Edema/etiologia , Edema/terapia , Previsões , Imunoglobulina E/uso terapêutico , Fragmentos Fab das Imunoglobulinas/uso terapêutico , Imunoterapia/tendências , Camundongos , Mordeduras de Serpentes/etiologia , Mordeduras de Serpentes/patologiaRESUMO
Aqueous extract from Casearia sylvestris leaves, a typical plant from Brazilian open pastures, was able to neutralize the hemorrhagic activity caused by Bothrops asper, Bothrops jararacussu, Bothrops moojeni, Bothrops neuwiedi and Bothrops pirajai venoms. It also neutralized two hemorrhagic metalloproteinases from Bothrops asper venom. Proteolytic activity on casein induced by bothropic venoms and by isolated proteases, including Bn2 metalloproteinase from B. neuwiedi venom, was also inhibited by the C. sylvestris extract in different levels. The alpha-fibrinogen chain was partially protected against degradation caused by B. jararacussu venom, when this venom was incubated with C. sylvestris extract. We also observed that this extract partially increased the time of plasma coagulation caused by B. jararacussu, B. moojeni and B. neuwiedi venoms. C. sylvestris extract did not induce proteolysis in any substrate assayed.
Assuntos
Bothrops/fisiologia , Venenos de Crotalídeos/antagonistas & inibidores , Inibidores Enzimáticos/farmacologia , Metaloendopeptidases/antagonistas & inibidores , Extratos Vegetais/farmacologia , Animais , Caseínas/metabolismo , Venenos de Crotalídeos/enzimologia , Fibrinogênio/metabolismo , Fibrinólise/efeitos dos fármacos , Hemorragia/patologia , Hemorragia/prevenção & controle , Metaloendopeptidases/metabolismo , Dermatopatias/patologia , Dermatopatias/prevenção & controleRESUMO
The adjuvant properties of several immunostimulant molecules on the murine antibody response to Bothrops asper snake venom were evaluated. Mice receiving venom together with either sodium alginate, calcium alginate, aluminum hydroxide, muramyl dipeptide, killed Brucella abortus or B. abortus smooth lipopolysaccharide developed a similar antibody response. Despite the fact that in some cases animals injected with venom and Salmonella montevideo lipopolysaccharide developed a significantly higher antibody titer when compared to other experimental groups, no statistically significant differences were observed in most of the comparisons.
Assuntos
Adjuvantes Imunológicos , Anticorpos/imunologia , Bothrops/imunologia , Venenos de Serpentes/imunologia , Animais , CamundongosRESUMO
BaP1 is a P-I class snake venom metalloproteinase (SVMP) relevant in the local tissue damage associated with envenomings by Bothrops asper, a medically important snake species in Central America and parts of South and North America. The main treatment for these accidents is the passive immunotherapy using antibodies raised in horses. In order to obtain more specific and batch-to-batch consistent antivenons, recombinant antibodies are considered a good option compared to animal immunization. We constructed a recombinant single chain variable fragment (scFv) from a monoclonal antibody against BaP1 (MABaP1) formerly secreted by a hybridoma clone. This recombinant antibody was cloned into pMST3 vector in fusion with SUMO protein and contains VH and VL domains linked by a flexible (G4S)3 polypeptide (scFvBaP1). The aim of this work was to produce scFvBaP1 and to evaluate its potential concerning the neutralization of biologically important activities of BaP1. The cytoplasmic expression of this construct was successfully achieved in C43 (DE3) bacteria. Our results showed that scFvBaP1-SUMO fusion protein presented an electrophoretic band of around 43 kDa from which SUMO alone corresponded to 13.6 kDa, and only the scFv was able to recognize BaP1 as well as the whole venom by ELISA. In contrast, neither an irrelevant scFv anti-LDL nor its MoAb partner recognized it. BaP1-induced fibrinolysis was significantly neutralized by scFvBaP1, but not by SUMO, in a concentration-dependent manner. In addition, scFvBaP1, as well as MaBaP1, completely neutralized in vivo hemorrhage, muscle necrosis, and inflammation induced by the toxin. Docking analyses revealed possible modes of interaction of the recombinant antibody with BaP1. Our data showed that scFv recognized BaP1 and whole B. asper venom, and neutralized biological effects of this SVMP. This scFv antibody can be used for understanding the molecular mechanisms of neutralization of SVMPs, and for exploring the potential of recombinant antibody fragments for improving the neutralization of local tissue damage in snakebite envenoming.
Assuntos
Antivenenos/farmacologia , Bothrops/metabolismo , Hemorragia/induzido quimicamente , Metaloproteases/antagonistas & inibidores , Metaloproteases/toxicidade , Venenos de Serpentes/antagonistas & inibidores , Proteínas Supressoras de Tumor/antagonistas & inibidores , Ubiquitina Tiolesterase/antagonistas & inibidores , Sequência de Aminoácidos , Animais , Especificidade de Anticorpos , Antivenenos/química , Escherichia coli/metabolismo , Feminino , Fragmentos de Imunoglobulinas/farmacologia , Inflamação/induzido quimicamente , Inflamação/prevenção & controle , Camundongos , Camundongos Endogâmicos BALB C , Dados de Sequência Molecular , Testes de Neutralização , Proteínas Recombinantes/química , Proteínas Recombinantes/farmacologia , Proteínas Supressoras de Tumor/química , Proteínas Supressoras de Tumor/imunologia , Ubiquitina Tiolesterase/química , Ubiquitina Tiolesterase/imunologiaRESUMO
BaP1 is a P-I class of Snake Venom Metalloproteinase (SVMP) relevant in the local tissue damage associated with envenomations by Bothrops asper, a medically-important species in Central America and parts of South America. Six monoclonal antibodies (MoAb) against BaP1 (MABaP1) were produced and characterized regarding their isotype, dissociation constant (K(d)), specificity and ability to neutralize BaP1-induced hemorrhagic and proteolytic activity. Two MABaP1 are IgM, three are IgG1 and one is IgG2b. The K(d)s of IgG MoAbs were in the nM range. All IgG MoAbs recognized conformational epitopes of BaP1 and B. asper venom components but failed to recognize venoms from 27 species of Viperidae, Colubridae and Elapidae families. Clone 7 cross-reacted with three P-I SVMPs tested (moojeni protease, insularinase and neuwiedase). BaP1-induced hemorrhage was totally neutralized by clones 3, 6 and 8 but not by clone 7. Inhibition of BaP1 enzymatic activity on a synthetic substrate by MABaP1 was totally achieved by clones 3 and 6, and partially by clone 8, but not by clone 7. In conclusion, these neutralizing MoAbs against BaP1 may become important tools to understand structure-function relationships of BaP1 and the role of P-I class SVMP in snakebite envenomation.
Assuntos
Anticorpos Monoclonais/biossíntese , Anticorpos Monoclonais/imunologia , Bothrops/fisiologia , Venenos de Crotalídeos/enzimologia , Metaloendopeptidases/imunologia , Animais , Anticorpos Monoclonais/isolamento & purificação , Reações Cruzadas , Venenos de Crotalídeos/antagonistas & inibidores , Venenos de Crotalídeos/toxicidade , Edema/induzido quimicamente , Edema/prevenção & controle , Ensaio de Imunoadsorção Enzimática , Mapeamento de Epitopos , Hemorragia/induzido quimicamente , Hemorragia/prevenção & controle , Immunoblotting , Imunoglobulinas , Injeções Intraperitoneais , Metaloendopeptidases/antagonistas & inibidores , Metaloendopeptidases/toxicidade , Camundongos , Camundongos Endogâmicos BALB C , Testes de NeutralizaçãoRESUMO
A serine proteinase with thrombin-like activity was isolated from the venom of the Central American pit viper Bothrops asper. Isolation was performed by a combination of affinity chromatography on aminobenzamidine-Sepharose and ion-exchange chromatography on DEAE-Sepharose. The enzyme accounts for approximately 0.13% of the venom dry weight and has a molecular mass of 32 kDa as determined by SDS-PAGE, and of 27 kDa as determined by MALDI-TOF mass spectrometry. Its partial amino acid sequence shows high identity with snake venom serine proteinases and a complete identity with a cDNA clone previously sequenced from this species. The N-terminal sequence of the enzyme is VIGGDECNINEHRSLVVLFXSSGFL CAGTLVQDEWVLTAANCDSKNFQ. The enzyme induces clotting of plasma (minimum coagulant dose = 4.1 microg) and fibrinogen (minimum coagulant dose = 4.2 microg) in vitro, and promotes defibrin(ogen)ation in vivo (minimum defibrin(ogen)ating dose = 1.0 microg). In addition, when injected intravenously in mice at doses of 5 and 10 microg, it induces a series of behavioral changes, i.e., loss of the righting reflex, opisthotonus, and intermittent rotations over the long axis of the body, which closely resemble the ;gyroxin-like' effect induced by other thrombin-like enzymes from snake venoms.
Assuntos
Coagulação Sanguínea , Bothrops , Coagulantes/isolamento & purificação , Venenos de Crotalídeos/enzimologia , Serina Endopeptidases/isolamento & purificação , Sequência de Aminoácidos , Animais , Antivenenos/uso terapêutico , Coagulação Sanguínea/efeitos dos fármacos , Cromatografia em Agarose , Cromatografia por Troca Iônica , Coagulantes/administração & dosagem , Coagulantes/farmacologia , Costa Rica , Avaliação Pré-Clínica de Medicamentos , Fibrinogênio/metabolismo , Camundongos , Serina Endopeptidases/química , Serina Endopeptidases/genética , Serina Endopeptidases/farmacologia , Mordeduras de Serpentes/fisiopatologia , Trombina/químicaRESUMO
The pathogenesis of hemorrhage and other local effects induced by the metalloproteinase BaP1, isolated from Bothrops asper venom, was investigated using various in vivo and in vitro models. Upon intramuscular injection in mice BaP1 caused rapid hemorrhage in muscular and adipose tissues. Vital microscopy using mouse cremaster muscle evidenced the formation of multiple hemorrhagic foci of an explosive character, originating from capillaries and small venules. In contrast to crude B. asper venom, which besides hemorrhage also induced myonecrosis and thrombosis, vital microscopy detected only hemorrhage after application of BaP1, during the 40-min observation period. However, histological observation in mouse gastrocnemius muscle evidenced a few areas of limited myonecrosis was followed by an incomplete regenerative response, since regenerating muscle fibers were interspersed with fibrosis in some areas. Metalloproteinase BaP1 was not cytotoxic to human and murine endothelial cells in culture, causing only a mild detachment from the culture plate. BaP1 hydrolyzed types I and IV collagen, fibronectin, and laminin upon incubation with these extracellular matrix proteins in vitro. These results suggest that hemorrhage induced by BaP1 is due primarily to the proteolytic degradation to basement membrane components of microvessels and that endothelial cell disruption may be a secondary event. It is concluded that, in addition to hemorrhage, BaP1 contributes to the local tissue damage caused by the venom by inducing myonecrosis, inflammation, and extracellular matrix alterations.
Assuntos
Venenos de Crotalídeos/enzimologia , Metaloendopeptidases/toxicidade , Animais , Bothrops , Creatina Quinase/sangue , Endotélio Vascular/enzimologia , Proteínas da Matriz Extracelular/metabolismo , Masculino , Camundongos , Músculos/efeitos dos fármacos , Músculos/ultraestruturaRESUMO
Blister formation and skin damage can be induced by BaP1, a haemorrhagic metalloproteinase from the venom of the snake Bothrops asper. Pathological changes in the skin were investigated after intramuscular injections of Bothrops asper haemorrhagic metalloproteinase BaP1. Blisters developed within the first hour, with separation of epidermis from the dermal-epidermal junction, whereas acantholysis of epithelial cells was not observed. After the third hour there was ulceration with formation of a proteinaceous scab and inflammatory infiltrate. By 7 to 14 days there was evidence of a regenerative process in dermis and epidermis. Haemorrhage occurred in both dermis and hypodermis as a consequence of BaP1 injection, together with damage of sebaceous glands and an inflammatory reaction in which enlarged macrophages were the predominant cell type. Zymography assays showed the presence of several endogenous metalloproteinases in the exudate, skin homogenates and plasma. In addition, BaP1 was detected in exudates and plasma by immunoblotting. This technique also demonstrated the presence of components immunologically related to laminin and collagen type IV in exudates. It is suggested that BaP1, and probably endogenous matrix metalloproteinases, degrade some protein components at the dermal-epidermal junction, inducing the formation of blisters.
Assuntos
Bothrops , Venenos de Crotalídeos/toxicidade , Metaloendopeptidases/toxicidade , Dermatopatias/induzido quimicamente , Animais , Vesícula/induzido quimicamente , Vesícula/enzimologia , Vesícula/patologia , Eletroforese em Gel de Poliacrilamida , Proteínas da Matriz Extracelular/metabolismo , Exsudatos e Transudatos/enzimologia , Exsudatos e Transudatos/metabolismo , Gelatinases/metabolismo , Immunoblotting , Metaloendopeptidases/metabolismo , Camundongos , Dermatopatias/enzimologia , Dermatopatias/patologiaRESUMO
Cerrophidion (Bothrops) godmani myotoxins I (CGMT-I) and II (CGMT-II), Asp-49 and Lys-49 phospholipases A(2) (PLA2s), which drastically differ in enzymatic activity, were devoid of direct hemolytic effects on erythrocytes (RBC) from different species despite the fact that enzymatically active CGMT-I was able to hydrolyze RBC membrane phospholipids and disrupt liposomes prepared from RBC lipids. Human RBC did not become susceptible to the toxins after treatment with neuraminidase or after altering membrane fluidity with cholesterol or sublytic concentrations of detergent. Unlike normal RBC, significant hemolysis was induced by CGMT-II and another similar Lys-49 isoform, B. asper MT-II (BAMT-II), in RBC enriched with phosphatidylserine (PS). Hemolysis was greater in RBC preincubated with pyridyldithioethylamine (PDA), a potent inhibitor of aminophospholipid transport. RBC enriched with phosphatidic acid (PA) also became susceptible to the myotoxins but was unaffected by PDA. Cells enriched with phosphatidylcholine (PC) remained resistant to the action of the toxins. BAMT-II also induced damage in black lipid membranes prepared with PS but not PC alone. When RBC binding of BAMT-II was measured by enzyme-linked immunosorbent assay, it was observed that PS- and PA-enriched erythrocytes were always able to capture more toxin than normal and PC-enriched RBC. This effect was significantly improved by PDA (in the case of PS) and it was observed either in the presence or in the absence of calcium in the medium. These data suggest that negatively charged lipids in the outer leaflet of cell membranes constitute myotoxic PLA2 binding sites. The scarcity of anionic phospholipids in the outer leaflet of RBC could explain their resistance to the action of these PLA2s.
Assuntos
Bothrops , Venenos de Crotalídeos/enzimologia , Eritrócitos/efeitos dos fármacos , Fosfolipases A/toxicidade , Fosfolipídeos/metabolismo , Animais , Membrana Celular/efeitos dos fármacos , Membrana Celular/metabolismo , Eritrócitos/metabolismo , Fosfolipases A2 do Grupo II , Humanos , Bicamadas Lipídicas/metabolismo , Lipossomos/metabolismo , Fluidez de Membrana/efeitos dos fármacos , Neuraminidase/metabolismo , Neurotoxinas/metabolismo , Neurotoxinas/toxicidade , Fosfolipases A/metabolismo , Fosfolipases A2 , Proteínas de Répteis , Especificidade da EspécieRESUMO
A new myotoxic phospholipase A2 was isolated from the venom of the arboreal snake Bothriechis schlegelii (formerly Bothrops schlegelii) from Costa Rica, by ion-exchange chromatography on CM-Sephadex. B. schlegelii myotoxin I is a basic protein (pI > 9.3) with a subunit molecular weight of 15 kDa, which migrates as a dimer in sodium dodecyl sulfate-polyacrylamide gel electrophoresis under nonreducing conditions. This myotoxin is recognized by antibodies generated against Bothrops asper myotoxin II (a lysine-49 phospholipase A2), by both enzyme-immunoassay and gel immunodiffusion, in the latter case with a pattern of partial identity. The toxin induces rapid myonecrosis upon intramuscular injection in mice, as evidenced by the early increase in plasma creatine kinase activity and by direct intravital microscopic observation. B. schlegelii myotoxin I also induces edema in the mouse footpad assay and exerts lethal activity (LD50 approximately 2.5 microg/g) upon intravenous injection. The toxin has a low phospholipase A2 activity (4.2 microEq.mg-1.min-1) using egg yolk phospholipids as substrate. It also shows a weak anticoagulant effect in vitro. Its N-terminal sequence, SMYELGKMILLETGKNAATSYIAYG, shows 93% homology with both Bothrops asper myotoxin II and B. jararacussu bothropstoxin I, suggesting that B. schlegelii myotoxin I may be a new lysine-49 variant of this family of myotoxic phospholipases A2.